Early Intervention, Extended Benefit: Transforming Tolerability Into Treatment Success in Later-Line Metastatic Colorectal Cancer

Please visit answersincme.com/860/103518989-replay2 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by John Strickler, MD and Tanios Bekaii-Saab, MD. In this activity, experts in metastatic colorectal cancer (mCRC) discuss proactive toxicity management and dose optimization strategies to help patients remain on treatment and improve outcomes. Upon completion of this activity, participants should be better able to: Integrate proactive management strategies to maintain patients on later-line therapy.